KRAS and neoplasm: Kras mutations alone are, however, not sufficient to induce PDAC progression to the invasive stage, and different tumor suppressor genes are typically deleted or inactivated to generate metastatic disease including Ink4, p53, Smad4 or TGFβ (52–56).